The Venture Codex Logo

The Venture Codex

CREAL

Chemin de la Dent d'Oche 1A, Ecublens, VD, 1024, Switzerland

Overview

CREAL develops proprietary light field display technology to deliver natural, comfortable, and healthy digital visual experiences. Its core products include a miniaturizing AR light field module intended for integration into lightweight, fashionable AR glasses and a digitized vision care platform. The vision care platform will be supplied under a licensing agreement to power ZEISS’ next-generation diagnostic and treatment devices. The company plans continued miniaturization of its AR module to target enterprise and eventually consumer markets. CREAL recently closed an $8.9 million equity funding round led by ZEISS, and the company has now raised over $32 million to date. Investors include Swisscom Ventures, Verve Ventures, DAA Capital Partners and members of the UBS private investor network. CREAL builds light-field display technology that projects genuinely three-dimensional, hologram-like imagery for AR glasses, allowing each eye to change focus naturally. The technology aims to solve the vergence–accommodation conflict that causes eye-strain and visual discomfort in current AR hardware. The new funding will help move the product from a hardware-development-kit stage to a complete technology package for next-generation and consumer-grade AR glasses. Founded in late 2017 and based in Lausanne, CREAL's team counts 18 people with engineering and research experience from Intel, Magic Leap, CERN, EPFL and several startups. To date the company has raised CHF 14.2 million across seed, Series A, an EU research grant, and the announced A+ round. CREAL expects the improved optics to broaden AR use cases and support adoption in both consumer and professional markets. CREAL develops light-field display technology that projects genuinely three-dimensional, near-retinal-resolution images enabling natural eye focus for VR and AR. The company’s displays let each eye change focus between virtual objects, addressing eyestrain and nausea from current stereoscopic systems. CREAL plans to move its technology from the current prototype stage to next-generation VR headsets and later AR headsets. Financially, it closed a CHF4.3M Series A and received additional public funding and a subsidized loan, bringing combined new support to CHF7.3M. The team was founded by Tomas Sluka, Alexander Kvasov and Tomas Kubes and includes engineers from the former Intel Vaunt project with ties to CERN and EPFL. CREAL previously closed a CHF0.85M seed round in May 2018 led by SICTIC investors. CREAL3D develops a light-field display for virtual-reality goggles and smart glasses that enables genuinely three-dimensional images and natural focus changes between virtual objects. Its technology aims to eliminate the eye-strain caused by fixed-focus dual-screen headsets and to allow conflictless mixing of real and virtual images. The company completed a proof-of-concept phase prior to its latest financing. Following a FIT seed loan, CREAL3D closed a seed financing to support further product development. The round brought in CHF 0.85 million. Investors include Swiss ICT Investor Club (SICTIC) as lead and private investors such as Jari Ovaskainen and Atmosclear Investments.

Total raised
$24M
Funding rounds
6
Latest round
Equity
Latest activity
Jul 2025

Industries

  • 3D Technology
  • Augmented Reality
  • Health Care
  • Software
  • Virtual Reality
Visit website

Recent funding

  1. Equity

    Jul 2025

    $9M

  2. Series A

    Nov 2020

    $7M

  3. Grant

    Dec 2019

    $3M

  4. Seed

    Jun 2018

    $1M

Team